SCHEMBL659733

SCHEMBL659733

COCOc1ccc(C(=O)CC(c2ccc(Cl)cc2)C(C(=O)OC)C(=O)OC)cc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.54
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
POLB P06746 2/20 0.42
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KCNH2 Q12809 1/20 0.39
FFAR1 O14842 1/20 0.39
KMT2A Q03164 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
MEN1 O00255 1/20 0.38
UTS2R Q9UKP6 1/20 0.38
CNR2 P34972 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL660221 0.89 POLB (0.49) L3MBTL1KDM4ELMNAMAPTPOLB
SCHEMBL660915 0.84 L3MBTL1 (0.60) L3MBTL1KDM4ELMNAMAPTPOLB
SCHEMBL659208 0.83 L3MBTL1 (0.59) L3MBTL1MAPTPOLBCYP2C9CYP2C19
SCHEMBL657922 0.81 CYP2C9 (0.61) L3MBTL1LMNAMAPTPOLBCYP2C9
SCHEMBL658474 0.80 PDPK1 (0.56) L3MBTL1MAPTPOLBUTS2RCNR2
SCHEMBL657267 0.77 L3MBTL1 (0.56) L3MBTL1LMNAMAPTPOLBCYP2C9
SCHEMBL23149235 0.76 L3MBTL1 (0.52) L3MBTL1MAPTPOLBCYP2C9CYP2C19
SCHEMBL3866097 0.76 MAPT (0.57) L3MBTL1KDM4ELMNAMAPTKMT2A
SCHEMBL7108403 0.75 L3MBTL1 (0.68) L3MBTL1KDM4ELMNAMAPTPOLB
SCHEMBL11598022 0.74 L3MBTL1 (0.44) L3MBTL1CYP2C19FFAR1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB L3MBTL1 3302/4885KDM4E 1893/4885LMNA 3119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.